Further reports showed that HGF/C-MET downstream intermediate phospholipase Cγ-1 (PLCγ-1) overexpression was also observed in breast cancer [9], and specific PLCγ-1 inhibition was found to block breast cancer invasiveness [10]. Here, HGF is linked to breast cancer.